RSRicardo Silva-Carvalho

Ricardo Silva-Carvalho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ricardo Silva-Carvalho has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimizing bacterial nanocellulose production in static culture with a new Komagataeibacter isolate

    by Ana Cristina Rodrigues, Andreia F. Salvador, Miguel Pacheco, Pedro Montenegro-Silva, Ricardo Silva-Carvalho, Daniela Martins, Gonçalo N. P. Oliveira, Miguel Gama, Fernando Dourado

  • Open Access

    Nanobubble-enhanced oxygen transfer in bacterial nanocellulose production: Comparative evaluation with static and airlift systems

    by Ana Cristina Rodrigues, Daniela Martins, Ricardo Silva-Carvalho, Susana Marques, Isabel Belo, Begoña Espiña, Fernando Dourado, Miguel Gama


  • Open Access

    Optimizing bacterial nanocellulose production from eucalyptus bark: A circular approach to wastewater management and resource recovery

    by Ana Cristina Rodrigues, Daniela Martins, M. Salomé Duarte, Ricardo Silva-Carvalho, Susana Marques, Ana Júlia Cavaleiro, Miguel Gama, Fernando Dourado


  • Bacterial Cellulose In Vitro Uptake by Macrophages, Epithelial Cells, and a Triculture Model of the Gastrointestinal Tract

    by Ricardo Silva-Carvalho, Patrícia M. Rodrigues, Daniela Martins, Ana Cristina Rodrigues, Paula Sampaio, Fernando Dourado, Catarina Gonçalves, Miguel Gama

    Bacterial cellulose (BC) has a long-standing human consumption history in different geographies without any report of adverse effects. Despite its unique textural and functional properties, the use of BC in food products in Europe is still restricted due to concerns over its nanosize. Here, we evaluated the potential uptake of celluloses (from plant and microbial sources, processed using different blenders) by macrophages (differentiated THP-1 cells) and human intestinal epithelial cells (Caco-2 and HT29-MTX cells) without (coculture) or with (triculture) Raji-B cells. A carbohydrate-binding module coupled to a green fluorescent protein was employed to observe cellulose in the cell cultures by confocal laser scanning microscopy and stimulated emission depletion microscopy. The methodology demonstrated excellent sensitivity, allowing detection of single nanocrystals within cells. All celluloses were taken up by the macrophages, without significantly compromising the cell's metabolic viability. The viability of the cocultures was also not affected. Furthermore, no internalization was observed in the triculture cell model that was exposed 24 h to BC and Avicel LM310. When (rarely) detected, cellulose particles were found on the apical side of the membrane. Overall, the obtained results suggest that BC should not be absorbed into the human gut.


  • Assessment of the gastrointestinal fate of bacterial nanocellulose and its toxicological effects after repeated-dose oral administration

    by Ana Cristina Rodrigues, Lígia Costa, Ricardo Silva-Carvalho, Renato Mota, Sara Duarte-Silva, Andreia Teixeira-Castro, Nuno Lamas, Gonçalo N. P. Oliveira, Yizao Wan, Fernando Dourado, et al.

    Bacterial nanocellulose (BNC), a nanofibrillar polysaccharide produced by certain acetic acid bacteria, may be used in food, pharma and many other applications. As with other nanoscale celluloses, the oral toxicology of BNC is still controversial. Therefore, we aimed to assess whether BNC is absorbed at the intestine following administration in Wistar rats. This is, to our knowledge, the first attempt to track in vivo the potential internalization of (nano)cellulose fibers. For 21 days, animals were subjected to daily oral gavage of an aqueous suspension 1% (w/v) BNC or of its counterpart of plant origin (Avicel LM310). During the assay, clinical observations, such as body weight measurements, food consumption and ophthalmologic evaluations were performed. After occision, serum chemistry, necropsy examination and histopathological analyses of the liver, kidneys, spleen and small and large intestines were performed. The presence of BNC fibers along the gastrointestinal tract was assessed histologically using a green fluorescence protein coupled to a cellulose carbohydrate binding module (GFP-CBM). No evidence of BNC persorption was found. Particularly, no BNC was detected in the Peyer's patches or in the mesenteric lymphatic nodules. Moreover, the histopathological analyses revealed that the global architecture and morphology of the organs and tissues were preserved, with no significant pathological changes being observed. Regarding serum biochemistry, no significant differences were recorded. These findings suggest that BC nanofibers are not absorbed at the intestine and can be considered a safe food additive.


  • Open Access

    Tracking Bacterial Nanocellulose in Animal Tissues by Fluorescence Microscopy

    by Renato Mota, Ana Cristina Rodrigues, Ricardo Silva-Carvalho, Lígia Costa, Daniela Martins, Paula Sampaio, Fernando Dourado, Miguel Gama

    The potential of nanomaterials in food technology is nowadays well-established. However, their commercial use requires a careful risk assessment, in particular concerning the fate of nanomaterials in the human body. Bacterial nanocellulose (BNC), a nanofibrillar polysaccharide, has been used as a food product for many years in Asia. However, given its nano-character, several toxicological studies must be performed, according to the European Food Safety Agency’s guidance. Those should especially answer the question of whether nanoparticulate cellulose is absorbed in the gastrointestinal tract. This raises the need to develop a screening technique capable of detecting isolated nanosized particles in biological tissues. Herein, the potential of a cellulose-binding module fused to a green fluorescent protein (GFP–CBM) to detect single bacterial cellulose nanocrystals (BCNC) obtained by acid hydrolysis was assessed. Adsorption studies were performed to characterize the interaction of GFP–CBM with BNC and BCNC. Correlative electron light microscopy was used to demonstrate that isolated BCNC may be detected by fluorescence microscopy. The uptake of BCNC by macrophages was also assessed. Finally, an exploratory 21-day repeated-dose study was performed, wherein Wistar rats were fed daily with BNC. The presence of BNC or BCNC throughout the GIT was observed only in the intestinal lumen, suggesting that cellulose particles were not absorbed. While a more comprehensive toxicological study is necessary, these results strengthen the idea that BNC can be considered a safe food additive.


  • Hyaluronic acid–amphotericin B nanocomplexes: a promising anti-leishmanial drug delivery system

    by R. Silva-Carvalho, T. Leão, A. I. Bourbon, C. Gonçalves, L. M. Pastrana, P. Parpot, I. Amorim, A. M. Tomás, F. M. Gama

    The development of an effective amphotericin B (AmB) formulation to replace actual treatments available for leishmaniasis, which present serious drawbacks, is a challenge. Here we report the development of hyaluronic acid–amphotericin B self-assembled nanocomplexes (HA–AmB), processed by freeze-drying (FD) or nano spray-drying (SD), using a simple process that favors the non-covalent drug–polysaccharide association in an amorphous state. These water-soluble formulations, which presented a nanometric size (300–600 nm), high colloidal stability (zeta potential around −39 mV) and an AmB loading (15–18%) in aggregated and super aggregated states, demonstrated less in vitro cytotoxic and hemolytic effects compared to the free-drug. A significant decrease in the number of intramacrophagic L. infantum amastigotes upon treatment (IC50 of 0.026 and 0.030 μM for HA–AmB FD and HA–AmB SD, respectively) was also observed, and the best selectivity index (SI) was observed for the HA–AmB SD nanocomplex (SI of 651). Intravenous administration of the HA–AmB SD nanocomplex for 3 alternate days showed an effective parasite reduction in the spleen and liver of C57BL/6 mice without signs of toxicity commonly observed upon free-AmB treatment. Although lower than that achieved with AmBisome® in the liver, the observed parasite reduction for the nanocomplex was of a similar order of magnitude. The efficacy, stability, safety and low cost of the HA–AmB SD nanocomplex highlight its potential as an alternative treatment for leishmaniasis.


  • Covalent Conjugation of Amphotericin B to Hyaluronic Acid: An Injectable Water-Soluble Conjugate with Reduced Toxicity and Anti-Leishmanial Potential

    by Ricardo Silva-Carvalho, Teresa Leão, Francisco M. Gama, Ana M. Tomás

    Amphotericin B (AmB) is a highly hydrophobic drug with significant leishmanicidal activity whose use is limited by its poor water solubility and adverse effects. Polymer-drug conjugates are proposed as a delivery system designed to overcome those limitations while improving drug bioavailability, safety, and activity. Here, AmB was covalently linked to periodate-oxidized hyaluronic acid (HA) (oxidation degree of 30.1 ± 5.6%) via a Schiff base (HA-AmB imine). The conjugate presents high water solubility and self-assembles into particles with a mean size of 88.2 ± 17.6 nm, a negative charge (−28.3 ± 0.9 mV), and a drug content of 17.8 ± 1.4%. Spectroscopic studies revealed the presence of AmB in aggregate and super-aggregated forms in the conjugate, which could explain the significant reduction of the in vitro cytotoxicity and hemolytic activity. The formulation showed not only in vitro anti-leishmanial activity against L. infantum-infected macrophages (IC50 = 0.023 μM) but also against an in vivo infected mouse model, promoting a 1.32- and a 4.98-log10 suppression of the L. infantum burden in the spleens and liver, respectively, without toxic effects. In summary, this study describes the safe and effective use of water-soluble HA-AmB imine conjugates for leishmaniasis treatment.


  • Grafting MSI-78A onto chitosan microspheres enhances its antimicrobial activity

    by Diana R. Fonseca, Ana Moura, Victoria Leiro, Ricardo Silva-Carvalho, Berta N. Estevinho, Catarina L. Seabra, Patrícia C. Henriques, Mónica Lucena, Cátia Teixeira, Paula Gomes, et al.


  • Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice

    by Patrícia C. Henriques, Lia M. Costa, Catarina L. Seabra, Bernardo Antunes, Ricardo Silva-Carvalho, Susana Junqueira-Neto, André F. Maia, Pedro Oliveira, Ana Magalhães, Celso A. Reis, et al.